104 related articles for article (PubMed ID: 10942872)
1. Measuring cell proliferation in the rectal mucosa. comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays.
Kulldorff M; McShane LM; Schatzkin A; Freedman LS; Wargovich MJ; Woods C; Purewal M; Burt RW; Lawson M; Mateski DJ; Lanza E; Corle DK; O'Brien B; Moler J
J Clin Epidemiol; 2000 Aug; 53(8):875-83. PubMed ID: 10942872
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
McShane LM; Kulldorff M; Wargovich MJ; Woods C; Purewal M; Freedman LS; Corle DK; Burt RW; Mateski DJ; Lawson M; Lanza E; O'Brien B; Lake W; Moler J; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):605-12. PubMed ID: 9681529
[TBL] [Abstract][Full Text] [Related]
3. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation.
Kubben FJ; Peeters-Haesevoets A; Engels LG; Baeten CG; Schutte B; Arends JW; Stockbrügger RW; Blijham GH
Gut; 1994 Apr; 35(4):530-5. PubMed ID: 7909785
[TBL] [Abstract][Full Text] [Related]
5. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
Kilias D; Macrae FA; Sharpe K; Young GP
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of epithelial cell proliferation in normal-appearing rectal mucosa of patients with colorectal adenoma and cancer using an in vitro labeling method with bromodeoxyuridine.
Ikeda N; Mizuno M; Okada H; Tomoda J; Tsuji T
Acta Med Okayama; 1994 Oct; 48(5):243-7. PubMed ID: 7863795
[TBL] [Abstract][Full Text] [Related]
7. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
[TBL] [Abstract][Full Text] [Related]
8. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators.
Macrae FA; Kilias D; Sharpe K; Hughes N; Young GP; MacLennan R
J Cell Biochem Suppl; 1994; 19():84-90. PubMed ID: 7823610
[TBL] [Abstract][Full Text] [Related]
9. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
[TBL] [Abstract][Full Text] [Related]
10. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological use of rectal proliferation measures.
Baron JA; Wargovich MJ; Tosteson TD; Sandler R; Haile R; Summers R; van Stolk R; Rothstein R; Weiss J
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):57-61. PubMed ID: 7894325
[TBL] [Abstract][Full Text] [Related]
12. Correlation between bromodeoxyuridine labelling and ornithine decarboxylase levels in normal rectal mucosa of patients with colorectal adenoma.
Paganelli GM; Saccoccio G; Brandi G; Bellentani S; Santucci R; Armocida C; Ponz de Leon M; Biasco G
Cancer Lett; 1991 Sep; 59(3):221-4. PubMed ID: 1913617
[TBL] [Abstract][Full Text] [Related]
13. Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium.
Weisgerber UM; Boeing H; Nemitz R; Raedsch R; Waldherr R
Gut; 1993 Nov; 34(11):1587-92. PubMed ID: 7902310
[TBL] [Abstract][Full Text] [Related]
14. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
15. The effect of a low-fat, high fiber, fruit and vegetable intervention on rectal mucosal proliferation.
Pfeiffer R; McShane L; Wargovich M; Burt R; Kikendall W; Lawson M; Lanza E; Schatzkin A
Cancer; 2003 Sep; 98(6):1161-8. PubMed ID: 12973839
[TBL] [Abstract][Full Text] [Related]
16. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
18. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
[TBL] [Abstract][Full Text] [Related]
19. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.
Keku TO; Galanko JA; Murray SC; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):993-9. PubMed ID: 9829707
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer].
Ota T; Akaza H; Hattori K; Uchida K
Nihon Hinyokika Gakkai Zasshi; 1997 Oct; 88(10):868-73. PubMed ID: 9388366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
